Table 2.
MiRNA expression results from meta-analysis.
| miRNAs | p-value | p-value FDR adjusted | Gene expression differences (BCVY –BCO) |
|---|---|---|---|
| hsa-mir-196a-1 | 3,92E-47 | 3,92E-46* | −0,28 |
| hsa-mir-184 | 1,31E-34 | 6,55E-34* | 0,26 |
| hsa-mir-9-1 | 6,12E-03 | 2,04E-02* | −0,13 |
| hsa-mir-551b | 1,45E-02 | 3,62E-02* | −0,38 |
| hsa-mir-548n | 1,46E-01 | 2,92E-01 | −0,06 |
| hsa-mir-383 | 3,49E-01 | 5,82E-01 | 0,28 |
| hsa-mir-548f-1 | 5,74E-01 | 8,21E-01 | −0,28 |
| hsa-mir-490 | 8,05E-01 | 9,65E-01 | 0,14 |
| hsa-mir-181c | 9,46E-01 | 9,65E-01 | 0,11 |
| hsa-mir-662 | 9,65E-01 | 9,65E-01 | −0,05 |
Table shows miRNA expression values from the meta-analysis of the 10 miRNAs common to the three studies: TCGA, Clariom D and Peña-Chilet et al. study23.
*Statistically significant p-values adjusted by Benjamini-Hochberg False Discovery Rate procedure (FDR p-values < 0.05) and gene expression differences ±0.1.